← Issue №18/ week of Nov 1, 2026/Motility

Acid-Lowering Agents in Functional Dyspepsia: Assessing the Role and Effectiveness of Proton Pump Inhibitors and Beyond.

From GI Signals issue №18: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Motility review · Oct 30, 2026 · J Neurogastro Motil · IF 3.4

Acid-Lowering Agents in Functional Dyspepsia: Assessing the Role and Effectiveness of Proton Pump Inhibitors and Beyond.

Guideline / reviewfunctional dyspepsiameta-analysissystematic review
Clinical takeawayMeta-analyses show PPIs beat placebo for global functional dyspepsia symptoms, most consistently for epigastric pain and burning; the review flags possible long-term effects and calls P-CABs promising but unproven against PPIs.
What it foundPPIs are superior to placebo for global symptom relief in FD, with the most consistent benefits observed for epigastric pain and burning.
ContextConfirms PPIs as the standard first-line therapy for FD, while highlighting newly discovered non-acid-related mechanisms and introducing P-CABs as a potential future option. Applies to FD patients with epigastric pain or burning.
Reinforcessuggested applicable standard· American College of Gastroenterology, 'ACG and CAG Clinical Guideline: Management of Dyspepsia', 2017

Decision at stakethe use of PPIs for functional dyspepsia

After excluding organic causes and confirming H. pylori test-of-cure, manage functional dyspepsia by eradicating H. pylori if positive and giving a PPI (4-8 weeks, dosed 30-60 min before meals); for persistent symptoms consider neuromodulators (e.g., low-dose TCAs like amitriptyline 10-50 mg QHS) for refractory cases, particularly in EPS, or prokinetics cautiously in selected PDS cases. Initial evaluation follows ACG/CAG 2017: test-and-treat H. pylori in patients under 60 without alarm features, and EGD for age ≥60, alarm features, or high gastric-cancer-risk groups. Add psychological therapies (CBT, gut-directed hypnotherapy) and lifestyle measures.

American College of Gastroenterology, 'ACG and CAG Clinical Guideline: Management of Dyspepsia', 2017 · reviewed 2026-07-21 ↗
Ma R, Xiao Y · Journal of Neurogastroenterology and Motility · IF 3.4 · PubMed ↗Permalink
← Read the whole of issue №18 Every paper GI Signals surfaces gets a page like this one. All issues